An Exploratory Phase IIa Study to Investigate the Biological Activity of Oral FX125L in Adult Patients with Mild to Moderate Asthma

Trial Profile

An Exploratory Phase IIa Study to Investigate the Biological Activity of Oral FX125L in Adult Patients with Mild to Moderate Asthma

Completed
Phase of Trial: Phase II

Latest Information Update: 05 May 2015

At a glance

  • Drugs FX 125L (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors STX Pharma
  • Most Recent Events

    • 02 May 2015 Status changed from recruiting to completed as reported by EU Clinical Trials Register record.
    • 30 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top